Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A mouse model for testing remyelinating therapies.
Adult-onset Krabbe disease presenting as acute hemiparesis and progressive demyelination detected by diffusion-weighted imaging.
Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis.
Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.
Cost of Illness of Multiple Sclerosis - A Systematic Review.
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.
Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.
Delayed administration of recombinant human erythropoietin reduces apoptosis and inflammation and promotes myelin repair and functional recovery following spinal cord compressive injury in rats.
Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.
Effects of Proton and Combined Proton and (56)Fe Radiation on the Hippocampus.
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology.
Neurodegeneration in MS and NMO: The Eye and the Blood.
Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.
Blockade of chemokine signaling in patients with multiple sclerosis.
Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.
Long-term poor rapport, lack of spontaneity and passive social withdrawal related to acute post-infectious encephalitis: a case report.
Biological Functions of Interferon β-1a Are Enhanced By Deamidation.
The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Commentary.
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
Normal Molecular Specification and Neurodegenerative Disease-Like Death of Spinal Neurons Lacking the SNARE-Associated Synaptic Protein Munc18-1.
Dilutional Hyponatremia during Hysteroscpic Surgery: Prevention and Treatment.
Increased Immune Reactivity to Central Nervous System Derived Naturally Presented Peptides in Patients with Active Multiple Sclerosis.

Pages